Research Development Corporation of Japan

Honda Motor Co., Ltd.

The Kitasato Institute

National Institute of Health

Takeshi Kurata

Michiyuki Matsuda

Hideaki Yoshida

Ukyo Ogata

Chikara Aizawa

Atsushi Okabe

Hikaru Asai

Shinichi Tamura

Takashi Nagamine

A belt-type continuously variable transmission includes an actual gear ratio calculation unit for calculating an actual gear ratio based on the rotation speed of a drive pulley and the rotation speed of a driven pulley, a reference gear ratio calculation unit for calculating a reference gear ratio by modifying the actual gear ratio based on an input torque and a driven pulley hydraulic pressure, and a condition determination unit for, in a case where the target gear ratio is an overdrive gear ratio, determining that at least part of rings of a belt is missing when the reference gear ratio is greater than or equal to a predetermined gear ratio and a drive pulley hydraulic pressure is greater than or equal to a predetermined hydraulic pressure.

Vehicular continuously variable transmission, vehicle equipped with vehicular continuously variable transmission, and method of controlling vehicular continuously variable transmission

The present invention provides a cDNA of DOCK180 gene, which has a nucleotide sequence of SEQ ID No: 1 and of which translation product binds to the proto-oncogene product CRK, a recombinant vector containing this cDNA, a DOCK180 protein expressed from the cDNA which has a amino acid sequence of SEQ ID No: 2, and an antibody to the DOCK180 protein. According to the present invention, It is possible to develop new diagnosing and therapeutic techniques using DOCK180 protein and antibody against the protein.

cDNA of dock 180 gene and dock180 protein

The present invention provides a cDNA of DOCK180 gene, which has a nucleotide sequence of SEQ ID NO: 1 and of which translation product binds to the proto-oncogene product CRK, a recombinant vector containing this cDNA, a DOCK180 protein expressed from the EDNA which has a amino acid sequence of SEQ ID NO: 2, and an antibody to the DOCK180 protein. According to the present invention, It is possible to develop new diagnosing and therapeutic techniques using DOCK180 protein and antibody against the protein.

cDNA of DOCK180 gene and DOCK180 protein

A vaccine preparation comprising in combination a vaccine and a toxin or subunit thereof as an effective component. The toxin is preferably a bacterial toxin, e.g. cholera toxin, staphylococcal .alpha.-hemolysin, staphylococcal .delta.-hemolysin, vibrio thermostable direct hemolysin, pertussis toxin or E. coli heat-labile toxin. The toxin can be a B subunit or a part of a B subunit of a toxin. The vaccine can be influenza vaccine, pertussis vaccine, Japanese encephalitis vaccine, mixed vaccine of pertussis, diphtheria and tetanus toxoid, hepatitis B vaccine, rota vaccine, measles vaccine, rubella vaccine, mumps vaccine, combined vaccine of measles, rubella and mumps, or mycoplasma vaccine. The ratio of vaccine to toxin or subunit thereof is 1:0.0001-1:10,000 (w/v). The vaccine can be intranasal vaccine, or can be in injectable form, spray form or oral administration form.

Vaccine preparation comprising a bacterial toxin adjuvant

Growing community of inventors

Tokyo, Japan

Takeshi Kurata